April target for General Electric/Amersham deal as EU grants approval
This article was originally published in Clinica
Executive Summary
The main obstacle to General Electric's acquisition of the UK's life science and contrast media group Amersham was overcome on January 21 when the European Commission's competition authorities cleared the deal without imposing any conditions. With US Department of Justice clearance already under its belt, GE intends to tie up the transaction "in early April".